N-terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma : investigation of plasma levels and molecular circulating form (s) using radioimmunoassays for pro-atrial natriuretic peptide (31-67) , pro-atrial natriuretic peptide (1-30) and atrial natriuretic peptide (99-126)
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; Macgregor, G.A.
Clinical Science (1979) 87(3): 311-317
1994
ISSN/ISBN: 0143-5221 Accession: 076766244
PDF emailed within 1 workday: $29.90
Related References
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; MacGregor, G.A. 1994: N-terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma: investigation of plasma levels and molecular circulating form(s) using radioimmunoassays for pro-atrial natriuretic peptide (31-67), pro-atrial natriuretic peptide (1-30) and atrial natriuretic peptide (99-126) Clinical Science 87(3): 311-317Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; Macgregor, G.A. 1994: N-Terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma Investigation of plasma levels and molecular circulating form using radioimmunoassays for pro-atrial natriuretic peptide , pro-atrial natriuretic peptide and atrial natriuretic peptide Clinical Science 87(3): 311-317
Maioli, E.; Camporeale, A.; Torricelli, C.; Campoccia, G.; Pacini, A. 1997: Plasma protein interference in atrial natriuretic peptide RIA: Large molecular weight atrial natriuretic peptide is a real circulating form Biochemical Archives 13(4): 297-305
Nishikimi, T.; Mori, Y.; Ishimura, K.; Tadokoro, K.; Yagi, H.; Yabe, A.; Horinaka, S.; Matsuoka, H. 2004: Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function American Journal of Medicine 116(8): 517-523
Buckley, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.J.; MacGregor, G.A. 1989: Immunoreactive N -terminal Pro-Atrial Natriuretic Peptide in Human Plasma: Plasma Levels and Comparisons with -Human Atrial Natriuretic Peptide in Normal Subjects, Patients with Essential Hypertension, Cardiac Transplant and Chronic Renal Failure Clinical Science 77(5): 573-579
Bucklay, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.J.; Macgregor, G.A. 1989: Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with α-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure Clinical Science (1979) 77(5): 573-579
Ekman, A.C.; Vakkuri, O.; Vuolteenaho, O.; Leppaluoto, J. 1994: Ethanol decreases nocturnal plasma levels of atrial natriuretic peptide (ANP 99-126) but not the N-terminal fragment of pro-atrial natriuretic peptide (ANP I-98) in man Clinical Science (1979) 86(3): 285-290
Ekman, A.C.; Vakkuri, O.; Vuolteenaho, O.; Leppäluoto, J. 1994: Ethanol decreases nocturnal plasma levels of atrial natriuretic peptide (ANP 99-126) but not the N-terminal fragment of pro-atrial natriuretic peptide (ANP 1-98) in man Clinical Science 86(3): 285-290
Omland, T.; Aakvaag, A.; Bonarjee, V.V.S.; Caidahl, K.; Lie, R.T.; Nilsen, D.W.T.; Sundsfjord, J.A.; Dickstein, K. 1996: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction : Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93(11): 1963-1969
Omland, T.; Aakvaag, A.; Bonarjee, V.V.; Caidahl, K.; Lie, R.T.; Nilsen, D.W.; Sundsfjord, J.A.; Dickstein, K. 1996: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93(11): 1963-1969
Boomsma, F.; Bhaggoe, U.M.; Man in 't Veld, A.J.; Schalekamp, M.A. 1996: Comparison of N-terminal pro-atrial natriuretic peptide and atrial natriuretic peptide in human plasma as measured with commercially available radioimmunoassay kits Clinica Chimica Acta; International Journal of Clinical Chemistry 252(1): 41-49
Buckley, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.; MacGregor, G.A. 1989: Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with alpha-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure Clinical Science 77(5): 573-579
Bruckley, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.J.; Macgregor, G.A. 1989: Immunoreactive amino terminal pro atrial natriuretic peptide in human plasma plasma levels and comparisons with alpha human atrial natriuretic peptide in normal subjects patients with essential hypertension cardiac transplant and chronic renal failure Clinical Science 77(5): 573-579
Daggubati, S.; Parks, J.R.; Overton, R.M.; Cintron, G.; Schocken, D.D.; Vesely, D.L. 1997: Comparison of atrial natriuretic peptide, brain natriuretic peptide, C-natriuretic peptide, adrenomedullin, N-terminal proatrial and probrain natriuretic peptides as indicators of early congestive heart failure Journal of Investigative Medicine 45(3): 211A
Pelkonen, M.; Luodonpää, M.; Vuolteenaho, O.; Pasanen, M.; Ruskoaho, H. 1996: Cocaine increases circulating levels of atrial natriuretic peptide and pro atrial natriuretic peptide N-terminal fragment in conscious rats European Journal of Pharmacology 304(1-3): 55-62
Chang, I.C.Y.; Chen, L.Y.; Chong, J.P.C.; Austin, E.; Quay, C.N.; Gong, L.; Mark Richards, A.; Ling, L.H. 2015: Plasma mid-regional pro-atrial natriuretic peptide and N-terminal pro-brain natriuretic peptide improve discrimination of lone atrial fibrillation International Journal of Cardiology 188: 10-12
Honkonen, E.L.; Kaukinen, L.; Pehkonen, E.J.; Kaukinen, S. 1997: Atrial natriuretic peptide and N-terminal atrial natriuretic peptide in plasma reflect right ventricular volumes following coronary artery surgery Acta Anaesthesiologica Scandinavica 41(6): 685-693
Gordon, R.D.; Tunny, T.J.; Klemm, S.A.; Hamlet, S.M. 1986: Elevated levels of plasma atrial natriuretic peptide in Bartter's syndrome fall to normal with indomethacin: implications for atrial natriuretic peptide regulation in man Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 4(6): S555-S558
Hayashi, Y.; Ohtani, M.; Hiraishi, T.; Kobayashi, Y. 2002: Postoperative synthetic human atrial natriuretic peptide infusion and oral spironolactone administration for a patient with giant atria and low plasma level of atrial natriuretic peptide Journal of Thoracic and Cardiovascular Surgery 124(1): 206-209
Yamada, T.; Murakami, Y.; Okada, T.; Okamoto, M.; Shimizu, T.; Toyama, J.; Yoshida, Y.; Tsuboi, N.; Ito, T.; Muto, M.; Kondo, T.; Inden, Y.; Hirai, M.; Murohara, T. 2006: Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation American Journal of Cardiology 97(12): 1741-1744